Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts is a research paper published in Journal of Thoracic and Cardiovascular Surgery (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA232056
NCI NIH HHS
Grant: R43 CA224731
NCI NIH HHS
Grant: R43 CA224739
NCI NIH HHS
Grant: R43 CA189215
NCI NIH HHS
Grant: R44 CA189215
NCI NIH HHS
Grant: R43 CA213538
NCI NIH HHS
Grant: R01 CA227433
National Institutes of Health
Grant: 5R01CA227433-05
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
National Institutes of Health
Grant: 5R01CA232056-03
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA
National Institutes of Health
Grant: 1R43CA213538-01A1
Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles
National Institutes of Health
Grant: 5R44CA189215-03
Treating Peritoneal Malignancies with Paclitaxel-Loaded Expansile Nanoparticles
Small Business Innovation Research
National Cancer Institute
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals